Sudeep Pharma's upcoming IPO aims to raise Rs 895 crore for its pharmaceutical and food ingredient business, including a new venture into battery chemicals. The company boasts marquee clients like Pfizer and Danone, with strong EBITDA margins. However, concerns exist regarding expensive implied valuation and working capital cycles.